Published in Trans R Soc Trop Med Hyg on March 01, 1991
Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol (1992) 1.97
The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria. Br J Clin Pharmacol (1992) 1.53
Sulfadoxine-pyrimethamine for the treatment of malaria. Trans R Soc Trop Med Hyg (1992) 0.75
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Abolition of cost-sharing is pro-poor: evidence from Uganda. Health Policy Plan (2005) 2.57
Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol (1983) 1.77
Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg (2006) 1.75
Pruritus and antimalarial drugs in Africans. Lancet (1989) 1.70
Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child (1994) 1.67
Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob Agents Chemother (2008) 1.65
Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens (1999) 1.54
Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. Am J Trop Med Hyg (2004) 1.51
The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus. Clin Pharmacol Ther (2000) 1.48
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet (1987) 1.46
Malaria in Nigeria: a revisit. Ann Trop Med Parasitol (1990) 1.38
Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop (2005) 1.37
Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg (1997) 1.36
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
The disposition of amodiaquine in Zambians and Nigerians with malaria. Br J Clin Pharmacol (1990) 1.34
Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Ann Trop Med Parasitol (2003) 1.29
Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol (1997) 1.27
Prognostic risk factors and post mortem findings in cerebral malaria in children. Trans R Soc Trop Med Hyg (1993) 1.22
Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol (1983) 1.21
In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. Am J Trop Med Hyg (1998) 1.21
The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol (1987) 1.11
The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1981) 1.09
Cerebral malaria in non-paediatric subjects resident in southwestern Nigeria. Afr J Med Med Sci (1993) 1.08
Congenital malaria in a hyperendemic area: a preliminary study. Ann Trop Paediatr (1993) 1.07
A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life. Acta Trop (1995) 1.06
Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol (1986) 1.03
Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol (1987) 1.01
Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria: II. Correlation of in vitro with in vivo sensitivity. Trans R Soc Trop Med Hyg (1981) 0.99
Studies on Plasmodium falciparum parasitemia and development of anemia in Nigerian infants during their first year of life. Am J Trop Med Hyg (1996) 0.97
In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop (2011) 0.97
Retinal haemorrhage in cerebral malaria. East Afr Med J (1997) 0.96
Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria. Parasitol Res (2006) 0.96
Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans. Eur J Clin Pharmacol (1992) 0.95
Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Trans R Soc Trop Med Hyg (1993) 0.95
Inhibition of metoprolol metabolism by chloroquine and other antimalarial drugs. J Pharm Pharmacol (1990) 0.94
Protein energy malnutrition and cerebral malaria in Nigerian children. J Trop Pediatr (1997) 0.92
Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg (1992) 0.91
Body temperature in the Nigerian neonate--comparison of axillary and rectal temperatures. Afr J Med Med Sci (1991) 0.90
An open randomized comparative study of intramuscular artemether and intravenous quinine in cerebral malaria in children. Trans R Soc Trop Med Hyg (1994) 0.90
Efficacy of herbal remedies used by herbalists in Oyo State Nigeria for treatment of Plasmodium falciparum infections--a survey and an observation. Afr J Med Med Sci (2004) 0.89
Hypertension in Africa and effectiveness of its management with various classes of antihypertensive drugs and in different socio-economic and cultural environments. Clin Exp Hypertens (1993) 0.89
Chloroquine Resistant Plasmodium falciparum in Nigeria: Relationship between pfcrt and pfmdr1 Polymorphisms, In-Vitro Resistance and Treatment Outcome. Open Trop Med J (2008) 0.88
Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Trop (1999) 0.87
The clinical manifestations of cerebral malaria among Nigerian children with the sickle cell trait. Ann Trop Paediatr (1997) 0.87
Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1991) 0.86
Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica (2005) 0.86
Malaria diagnosis: false negative parasight-F tests in falciparum malaria patients in Nigeria. Afr J Med Med Sci (2004) 0.86
Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans R Soc Trop Med Hyg (1991) 0.85
Comparative study of interactions between chloroquine and chlorpheniramine or promethazine in healthy volunteers: a potential combination-therapy phenomenon for resuscitating chloroquine for malaria treatment in Africa. Ann Trop Med Parasitol (2008) 0.85
Evaluation of the sensitivity in vivo and in vitro of Plasmodium falciparum malaria to quinine in an area of full sensitivity to chloroquine. Trans R Soc Trop Med Hyg (1988) 0.85
Effect of HIV/AIDS on household welfare in Uganda rural communities: a review. East Afr Med J (2008) 0.85
Drug supply in Nigeria. J Clin Epidemiol (1991) 0.84
Pharmacokinetics of quinine in African patients with acute falciparum malaria. Pharm World Sci (1998) 0.84
Pharmacokinetics of chloroquine in renal insufficiency. Afr J Med Med Sci (1985) 0.83
Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg (2002) 0.83
Exposure to cyanide following a meal of cassava food. Toxicol Lett (2002) 0.82
Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ (1990) 0.82
Effect of Plasmodium falciparum malaria on plasma fibrinopeptide-A (FpA) concentration. Cent Afr J Med (1995) 0.81
The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ibadan, Nigeria. Trans R Soc Trop Med Hyg (1984) 0.81
Acute psychosis after mefloquine. Report of six cases. Trop Geogr Med (1995) 0.81
The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans R Soc Trop Med Hyg (1992) 0.81
The pharmacokinetics of caffeine in Nigerian children suffering from malaria and kwashiorkor. Eur J Clin Pharmacol (2000) 0.80
Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine. Bull World Health Organ (1987) 0.80
Plasmodium falciparum malaria in Nigerian children during high and low transmission seasons: gametocyte carriage and response to oral chloroquine. J Trop Pediatr (2005) 0.80
The effects of alpha1-acid glycoprotein on the reversal of chloroquine resistance in Plasmodium falciparum. Ann Trop Med Parasitol (2006) 0.79
Pharmacokinetics of quinine in African children suffering from kwashiorkor. Br J Clin Pharmacol (1989) 0.79
Pitfalls in the diagnosis of malaria: a-parasitaemic severe malaria. J Trop Pediatr (1992) 0.79
The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians. Eur J Clin Pharmacol (2000) 0.79
Comparative efficacy of chloroquine and cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in Nigerian children. Cent Afr J Med (2003) 0.79
Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc (1994) 0.78
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Ann Trop Med Parasitol (1992) 0.78
Hyperparasitaemia: not a reliable indicator of severity or poor prognosis in falciparum malaria in children in endemic African countries. Ann Trop Paediatr (1992) 0.78
Therapeutic monitoring of chloroquine in pregnant women with malaria. West Afr J Med (2003) 0.78
Respiratory distress adversely affects the outcome of childhood cerebral malaria. Trans R Soc Trop Med Hyg (1996) 0.78
Neuropsychiatric side effects of mefloquine in Africans. Trans R Soc Trop Med Hyg (1993) 0.77
Amlodipine as monotherapy in hypertensive Africans: clinical efficacy and safety studies. Afr J Med Med Sci (1996) 0.77
Pharmacokinetics of pindolol in Africans. Experientia (1979) 0.77
beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans. Eur J Clin Pharmacol (1979) 0.77
Height and weight measurements of Ibadan school children. Afr J Med Med Sci (1996) 0.77
Evaluation of lacidipine (a calcium blocker) in the treatment of hypertension in black African people: a double-blind comparison with hydrochlorothiazide. Afr J Med Med Sci (1999) 0.77
Plasmodium berghei: efficacy and safety of combinations of chloroquine and promethazine in chloroquine resistant infections in gravid mice. Afr J Med Med Sci (2004) 0.77
Cotrimoxazole in the treatment of acute uncomplicated falciparum malaria in nigerian children : a controlled clinical trial. Clin Drug Investig (2004) 0.77
CHOLERA EPIDEMIOLOGY IN ZAMBIA FROM 2000 TO 2010: IMPLICATIONS FOR IMPROVING CHOLERA PREVENTION AND CONTROL STRATEGIES IN THE COUNTRY. East Afr Med J (2013) 0.77
Congenital malaria in a hyperendemic area: a revisit. Afr J Med Med Sci (2001) 0.77
Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg (1994) 0.76